Amyotrophic Lateral Sclerosis
Membership Organizations · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7507 Standish Pl, Derwood, Maryland, 208...Phone Number
(301) 978-9855Website
webdc.alsa.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis is a company that operates in the Membership Organizations industry. It employs 20to49 people and has 1Mto5M of revenue. The company is headquartered in Derwood, Maryland.Explore more
Popular SearchesAmyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis AssociationALS AssociationSIC Code 65,653NAICS Code 81,813Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amyotrophic Lateral Sclerosis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Amyotrophic Lateral Sclerosis recently announced quarterly report
Amyotrophic Lateral Sclerosis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Amyotrophic Lateral Sclerosis launches new products
Check out if Amyotrophic Lateral Sclerosis is spiking on competitors!
Funding: Get notified immidiatlly once Amyotrophic Lateral Sclerosis has new funding data
Congratulate Masked Content for being promoted to Masked Content at Amyotrophic Lateral Sclerosis
Click to see if Amyotrophic Lateral Sclerosis had a recent Job posting/layoffs
Check if Amyotrophic Lateral Sclerosis has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Amyotrophic Lateral Sclerosis as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Amyotrophic Lateral Sclerosis is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Amyotrophic Lateral Sclerosis is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Amyotrophic Lateral Sclerosis.
Amyotrophic Lateral Sclerosis News & Media
PrimeC New Data to Be Presented at AD/PD™ 2026 Conference
Dr. Christian Lunetta to Present "From PARADIGM to PARAGON: Advancing PrimeC for ALS through Phase 2 Clinical and Biomarker Insights toward a Global Phase 3 Trial" CAMBRIDGE, Mass., March 18, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage...Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
TOKYO, Nov 20, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has been launched in Japan as a treatment for slowing progression of functionalimpairment in amyotrophic lateral sclerosis. The product received manufacturing and marketing approval in Japan on September 24, 2024, and was published in Japan’s National Health Insurance Drug Price List today. This approval is based on the resuNeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
12-month data demonstrated regulation of iron levels, which aligns with improved ALS survival and disease mitigation Previous results showed PrimeC slowed disease progression by 36% and improved survival rates, highlighting its potential as a transformative ALS therapy CAMBRIDGE, Mass.,...Coya Therapeutics to Present Novel Biomarker Survival Data in Large Cohort of ALS (Amyotrophic Lateral Sclerosis) Patients at Society of Neuroimmune Pharmacology Conference
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya’s Scientific Advisory Board, will present data on its novel oxidative stress biomarker candidate from a large cohort of Amyotrophic Lateral Sclerosis (ALS) patients at the upcoming Society of Neuroimmune Pharmacology Conference being h
Read more news
Top Membership Organizations Companies
See more top companies
Frequently Asked Questions Regarding Amyotrophic Lateral Sclerosis
Sign Up For FreeTo access detailed company insights
Amyotrophic Lateral Sclerosis is a company that operates in the Membership Organizations industry. It employs 20to49 people and has 1Mto5M of revenue. The company is headquartered in Derwood, Maryland.... Read More
